Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

FDA approves Protopic for the treatment of eczema

Dec. 11, 2000

NicOx's HCT-1026 shows promise for treatment of skin inflammation

Nov. 29, 2000

Dusa moves Levulan into phase I/II for the treatment of acne

Nov. 29, 2000

Phytopharm begins phase II trial of P-45 for alopecia areata

Nov. 28, 2000

Angiotech begins phase II trial with micellar paclitaxel for psoriasis

Nov. 27, 2000

Licensing opportunity from NIH: smad3 protein inhibition to enhance wound healing

Nov. 20, 2000

Steroid-free eczema treatment recommended for FDA approval

Nov. 17, 2000

Cellegy seeks approval of Rectogesic in New Zealand

Nov. 15, 2000

MBI-594AN advances to phase II for treatment of acne

Nov. 10, 2000

Connetics' foam formulation for scalp dermatoses launched in U.S.

Nov. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...